关于 Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
总部251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
成立2018
状态营业中

专利1 项专利

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

在 Heelky 上搜索所有专利 →

评论

暂无评价。与 Assertio Therapeutics, Inc. 合作过?来第一个分享你的经历吧。

撰写评价 →

地点

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

这是你的公司吗?

免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。

认领此页面

分享此公司

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

复制链接

分享到

二维码

用手机相机扫描即可打开此页面,也可以下载用于传单、幻灯片或胸牌。

加入 Heelky,建立联系、招聘人才、实现成长

创建免费账户,即可给他人发消息、申请职位并发布任务。

立即加入 — 完全免费

选择语言

Heelky 会记住你的选择。

其他语言

可用语言:70 关于 Heelky 的语言